Significant increase in hEGF uptake is correlated with formation of EGFR dimers induced by the EGFR tyrosine kinase inhibitor gefitinib

Podobne zapisy

• Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib
  od: Irwin, Mary E., i wsp.
  Wydane: (2011)
• Molecular Characteristics Predict Clinical Outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene
  od: Rizvi, Naiyer A., i wsp.
  Wydane: (2011)
• Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib
  od: Oxnard, Geoffrey R., i wsp.
  Wydane: (2011)
• Molecular Pharming of the Recombinant Protein hEGF-hEGF Concatenated with Oleosin Using Transgenic Arabidopsis
  od: Qiang, Weidong, i wsp.
  Wydane: (2020)
• Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs
  od: Cao, Cong, i wsp.
  Wydane: (2008)